Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
July 15 2022 - 9:40AM
Edgar (US Regulatory)
00017570972022-01-012022-03-310001757097cntg:MaximumAdditionalRestrictedStockUnitMembercntg:IfrsChiefExecutiveOfficerMember2022-02-010001757097ifrs-full:Level3OfFairValueHierarchyMemberifrs-full:RecurringFairValueMeasurementMember2022-03-310001757097cntg:WarrantsMember2022-01-012022-03-310001757097cntg:CapitalReserveAfterIssuanceOfSharesAndTransactionCostsMember2022-01-012022-01-310001757097ifrs-full:FinancialLiabilitiesMemberifrs-full:CurrencyRiskMembercurrency:USD2022-03-310001757097cntg:TradeReceivablesAndOtherAssetsMemberifrs-full:CurrencyRiskMembercurrency:USD2022-03-310001757097cntg:TradeReceivablesAndOtherAssetsMemberifrs-full:CurrencyRiskMembercurrency:INR2022-03-310001757097cntg:TradePayableAndOtherLiabilitiesMemberifrs-full:CurrencyRiskMembercurrency:USD2022-03-310001757097ifrs-full:CurrencyRiskMembercurrency:USD2022-03-310001757097ifrs-full:CurrencyRiskMembercurrency:INR2022-03-310001757097cntg:TradeReceivablesAndOtherAssetsMemberifrs-full:CurrencyRiskMembercurrency:USD2021-12-310001757097cntg:TradeReceivablesAndOtherAssetsMemberifrs-full:CurrencyRiskMembercurrency:INR2021-12-310001757097cntg:TradePayableAndOtherLiabilitiesMemberifrs-full:CurrencyRiskMembercurrency:USD2021-12-310001757097cntg:TradePayableAndOtherLiabilitiesMemberifrs-full:CurrencyRiskMembercurrency:INR2021-12-310001757097ifrs-full:CurrencyRiskMembercurrency:USD2021-12-310001757097ifrs-full:CurrencyRiskMembercurrency:INR2021-12-310001757097srt:NorthAmericaMembercntg:PharmaceuticalSegmentMember2022-01-012022-03-310001757097srt:NorthAmericaMembercntg:DiagnosticsSegmentMember2022-01-012022-03-310001757097srt:LatinAmericaMembercntg:PharmaceuticalSegmentMember2022-01-012022-03-310001757097srt:LatinAmericaMembercntg:DiagnosticsSegmentMember2022-01-012022-03-310001757097srt:EuropeMembercntg:PharmaceuticalSegmentMember2022-01-012022-03-310001757097srt:EuropeMembercntg:DiagnosticsSegmentMember2022-01-012022-03-310001757097srt:AsiaPacificMembercntg:DiagnosticsSegmentMember2022-01-012022-03-310001757097ifrs-full:PerformanceObligationsSatisfiedOverTimeMembercntg:PharmaceuticalSegmentMember2022-01-012022-03-310001757097ifrs-full:PerformanceObligationsSatisfiedOverTimeMembercntg:DiagnosticsSegmentMember2022-01-012022-03-310001757097ifrs-full:PerformanceObligationsSatisfiedAtPointInTimeMembercntg:PharmaceuticalSegmentMember2022-01-012022-03-310001757097country:UScntg:PharmaceuticalSegmentMember2022-01-012022-03-310001757097country:UScntg:DiagnosticsSegmentMember2022-01-012022-03-310001757097country:SAcntg:DiagnosticsSegmentMember2022-01-012022-03-310001757097country:NLcntg:DiagnosticsSegmentMember2022-01-012022-03-310001757097country:DEcntg:DiagnosticsSegmentMember2022-01-012022-03-310001757097cntg:IfrsMiddleEastMembercntg:PharmaceuticalSegmentMember2022-01-012022-03-310001757097cntg:IfrsMiddleEastMembercntg:DiagnosticsSegmentMember2022-01-012022-03-310001757097srt:NorthAmericaMember2022-01-012022-03-310001757097srt:LatinAmericaMember2022-01-012022-03-310001757097srt:EuropeMember2022-01-012022-03-310001757097srt:AsiaPacificMember2022-01-012022-03-310001757097ifrs-full:PerformanceObligationsSatisfiedOverTimeMember2022-01-012022-03-310001757097ifrs-full:PerformanceObligationsSatisfiedAtPointInTimeMember2022-01-012022-03-310001757097country:US2022-01-012022-03-310001757097country:SA2022-01-012022-03-310001757097country:NL2022-01-012022-03-310001757097country:DE2022-01-012022-03-310001757097cntg:PharmaceuticalSegmentMember2022-01-012022-03-310001757097cntg:IfrsMiddleEastMember2022-01-012022-03-310001757097cntg:DiagnosticsSegmentMember2022-01-012022-03-310001757097srt:NorthAmericaMembercntg:PharmaceuticalSegmentMember2021-01-012021-03-310001757097srt:NorthAmericaMembercntg:DiagnosticsSegmentMember2021-01-012021-03-310001757097srt:LatinAmericaMembercntg:PharmaceuticalSegmentMember2021-01-012021-03-310001757097srt:LatinAmericaMembercntg:DiagnosticsSegmentMember2021-01-012021-03-310001757097srt:EuropeMembercntg:PharmaceuticalSegmentMember2021-01-012021-03-310001757097srt:EuropeMembercntg:DiagnosticsSegmentMember2021-01-012021-03-310001757097srt:AsiaPacificMembercntg:DiagnosticsSegmentMember2021-01-012021-03-310001757097ifrs-full:PerformanceObligationsSatisfiedOverTimeMembercntg:PharmaceuticalSegmentMember2021-01-012021-03-310001757097ifrs-full:PerformanceObligationsSatisfiedOverTimeMembercntg:DiagnosticsSegmentMember2021-01-012021-03-310001757097ifrs-full:PerformanceObligationsSatisfiedAtPointInTimeMembercntg:PharmaceuticalSegmentMember2021-01-012021-03-310001757097country:UScntg:PharmaceuticalSegmentMember2021-01-012021-03-310001757097country:UScntg:DiagnosticsSegmentMember2021-01-012021-03-310001757097country:SAcntg:DiagnosticsSegmentMember2021-01-012021-03-310001757097country:NLcntg:DiagnosticsSegmentMember2021-01-012021-03-310001757097country:DEcntg:DiagnosticsSegmentMember2021-01-012021-03-310001757097cntg:IfrsMiddleEastMembercntg:PharmaceuticalSegmentMember2021-01-012021-03-310001757097cntg:IfrsMiddleEastMembercntg:DiagnosticsSegmentMember2021-01-012021-03-310001757097srt:NorthAmericaMember2021-01-012021-03-310001757097srt:LatinAmericaMember2021-01-012021-03-310001757097srt:EuropeMember2021-01-012021-03-310001757097srt:AsiaPacificMember2021-01-012021-03-310001757097ifrs-full:PerformanceObligationsSatisfiedOverTimeMember2021-01-012021-03-310001757097ifrs-full:PerformanceObligationsSatisfiedAtPointInTimeMember2021-01-012021-03-310001757097country:US2021-01-012021-03-310001757097country:SA2021-01-012021-03-310001757097country:NL2021-01-012021-03-310001757097country:DE2021-01-012021-03-310001757097cntg:PharmaceuticalSegmentMember2021-01-012021-03-310001757097cntg:IfrsMiddleEastMember2021-01-012021-03-310001757097cntg:DiagnosticsSegmentMember2021-01-012021-03-310001757097country:US2022-03-310001757097country:US2021-12-310001757097cntg:LoanFacilityTrancheOneMember2022-01-312022-01-310001757097cntg:PharmaceuticalPartnerMembercntg:PharmaceuticalSegmentMember2021-01-012021-03-310001757097ifrs-full:OrdinarySharesMember2022-03-310001757097ifrs-full:OrdinarySharesMember2021-12-310001757097cntg:StockOptionsMembercntg:LongTermIncentivePlanMember2021-12-310001757097cntg:StockOptionsMembercntg:EquityShareOption2017EquitySettledMember2021-12-310001757097cntg:IfrsRestrictedStockUnitsRsusMembercntg:LongTermIncentivePlanMember2021-12-310001757097cntg:IfrsRestrictedStockUnitsRsusMembercntg:LeadershipTransitionMembercntg:ChiefInformationOfficerMember2022-06-292022-06-290001757097cntg:MaximumAdditionalRestrictedStockUnitMembercntg:IfrsChiefExecutiveOfficerMembercntg:ScenarioChangeInControlOfEntityMember2022-02-012022-02-010001757097cntg:TimeBasedRestrictedStockUnitsMembercntg:IfrsChiefFinancialOfficerMembercntg:LeadershipTransitionMember2022-06-222022-06-220001757097cntg:PerformanceBasedRestrictedStockUnitsMembercntg:IfrsChiefFinancialOfficerMembercntg:LeadershipTransitionMember2022-06-222022-06-220001757097cntg:MaximumAdditionalRestrictedStockUnitMembercntg:IfrsChiefExecutiveOfficerMembercntg:VolumeWeightedAverageStockPricePriorToChangeMoreThanUsd15Member2022-02-012022-02-010001757097cntg:MaximumAdditionalRestrictedStockUnitMembercntg:IfrsChiefExecutiveOfficerMembercntg:VolumeWeightedAverageStockPricePriorToChangeBetweenUsd5AndUsd15Member2022-02-012022-02-010001757097cntg:IfrsRestrictedStockUnitsRsusMembercntg:ShareBasedAwardsSubjectToTimeVestingMembercntg:IfrsChiefExecutiveOfficerMember2022-02-012022-02-010001757097cntg:IfrsRestrictedStockUnitsRsusMembercntg:ShareBasedAwardsSubjectToTimeVestingAndPerformanceVestingMembercntg:IfrsChiefExecutiveOfficerMember2022-02-012022-02-010001757097cntg:IfrsRestrictedStockUnitsRsusMembercntg:ManagementBoardAndEmployeesMembercntg:LongTermIncentivePlanMember2022-02-012022-02-010001757097cntg:RsuGrantedFourMemberifrs-full:TopOfRangeMembercntg:LongTermIncentivePlanMember2022-01-012022-03-310001757097cntg:IfrsRestrictedStockUnitsRsusMembercntg:IfrsFormerChiefExecutiveOfficerMemberifrs-full:TopOfRangeMember2022-04-302022-04-300001757097cntg:BankOverdraftsOneAndThreeMember2022-03-310001757097cntg:BankOverdraftsOneAndThreeMember2021-12-310001757097ifrs-full:Level2OfFairValueHierarchyMemberifrs-full:RecurringFairValueMeasurementMember2022-03-310001757097ifrs-full:RecurringFairValueMeasurementMember2022-03-310001757097ifrs-full:FinancialLiabilitiesAtAmortisedCostMember2022-03-310001757097ifrs-full:RecurringFairValueMeasurementMember2021-12-310001757097ifrs-full:IssuedCapitalMember2021-01-012021-03-310001757097ifrs-full:CapitalReserveMember2021-01-012021-03-310001757097cntg:SecuredBankLoanMember2022-03-310001757097cntg:OverdraftFacilityMember2022-03-310001757097cntg:SecuredBankLoanMember2021-12-310001757097cntg:OverdraftFacilityOneMember2021-12-310001757097cntg:OverdraftFacilityMember2021-12-310001757097cntg:UnallocatedAmountsShareBasedPaymentsMember2022-01-012022-03-310001757097cntg:UnallocatedAmountsShareBasedPaymentsMember2021-01-012021-03-310001757097srt:ChiefExecutiveOfficerMember2022-01-012022-03-310001757097cntg:SupervisoryBoardMember2022-01-012022-03-310001757097cntg:ManagementBoardAndEmployeesMember2022-01-012022-03-310001757097cntg:ForfeitureOfManagementBoardGrantsMember2022-01-012022-03-310001757097cntg:ExpectedForfeitureOfManagementBoardGrantsMember2022-01-012022-03-310001757097srt:ChiefExecutiveOfficerMember2021-01-012021-03-310001757097cntg:SupervisoryBoardMember2021-01-012021-03-310001757097cntg:ManagementBoardAndEmployeesMember2021-01-012021-03-310001757097cntg:PartneringLaboratoryPhysicianProfDrPeterBauerMember2021-08-070001757097ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-03-310001757097ifrs-full:NoncontrollingInterestsMember2022-03-310001757097ifrs-full:IssuedCapitalMember2022-03-310001757097ifrs-full:EquityAttributableToOwnersOfParentMember2022-03-310001757097ifrs-full:CapitalReserveMember2022-03-310001757097cntg:RetainedEarningsExcludingCurrencyTranslationReserveMember2022-03-310001757097ifrs-full:ReserveOfExchangeDifferencesOnTranslationMembersrt:ScenarioPreviouslyReportedMember2021-12-310001757097ifrs-full:NoncontrollingInterestsMembersrt:ScenarioPreviouslyReportedMember2021-12-310001757097ifrs-full:IssuedCapitalMembersrt:ScenarioPreviouslyReportedMember2021-12-310001757097ifrs-full:EquityAttributableToOwnersOfParentMembersrt:ScenarioPreviouslyReportedMember2021-12-310001757097ifrs-full:EquityAttributableToOwnersOfParentMembersrt:RevisionOfPriorPeriodReclassificationAdjustmentMember2021-12-310001757097ifrs-full:CapitalReserveMembersrt:ScenarioPreviouslyReportedMember2021-12-310001757097cntg:RetainedEarningsExcludingCurrencyTranslationReserveMembersrt:ScenarioPreviouslyReportedMember2021-12-310001757097cntg:RetainedEarningsExcludingCurrencyTranslationReserveMembersrt:RevisionOfPriorPeriodReclassificationAdjustmentMember2021-12-310001757097ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-12-310001757097ifrs-full:NoncontrollingInterestsMember2021-12-310001757097ifrs-full:IssuedCapitalMember2021-12-310001757097ifrs-full:EquityAttributableToOwnersOfParentMember2021-12-310001757097ifrs-full:CapitalReserveMember2021-12-310001757097cntg:RetainedEarningsExcludingCurrencyTranslationReserveMember2021-12-310001757097ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-03-310001757097ifrs-full:NoncontrollingInterestsMember2021-03-310001757097ifrs-full:IssuedCapitalMember2021-03-310001757097ifrs-full:EquityAttributableToOwnersOfParentMember2021-03-310001757097ifrs-full:CapitalReserveMember2021-03-310001757097cntg:RetainedEarningsExcludingCurrencyTranslationReserveMember2021-03-310001757097ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2020-12-310001757097ifrs-full:NoncontrollingInterestsMember2020-12-310001757097ifrs-full:IssuedCapitalMember2020-12-310001757097ifrs-full:EquityAttributableToOwnersOfParentMember2020-12-310001757097ifrs-full:CapitalReserveMember2020-12-310001757097cntg:RetainedEarningsExcludingCurrencyTranslationReserveMember2020-12-310001757097cntg:PerformanceBasedRestrictedStockUnitsMember2022-01-012022-03-310001757097cntg:UnallocatedAmountsDepreciationAndAmortizationMember2022-01-012022-03-310001757097cntg:UnallocatedAmountsDepreciationAndAmortizationMember2021-01-012021-03-310001757097ifrs-full:DiscontinuedOperationsMemberifrs-full:FinancialEffectOfCorrectionsOfAccountingErrorsMember2022-01-012022-03-310001757097ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-01-012022-03-310001757097ifrs-full:NoncontrollingInterestsMember2022-01-012022-03-310001757097ifrs-full:IssuedCapitalMember2022-01-012022-03-310001757097ifrs-full:EquityAttributableToOwnersOfParentMember2022-01-012022-03-310001757097ifrs-full:CapitalReserveMember2022-01-012022-03-310001757097cntg:RetainedEarningsExcludingCurrencyTranslationReserveMember2022-01-012022-03-310001757097ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-01-012021-03-310001757097ifrs-full:NoncontrollingInterestsMember2021-01-012021-03-310001757097ifrs-full:EquityAttributableToOwnersOfParentMember2021-01-012021-03-310001757097cntg:RetainedEarningsExcludingCurrencyTranslationReserveMember2021-01-012021-03-3100017570972021-03-3100017570972020-12-310001757097cntg:CapitalReserveAfterIssuanceOfSharesWarrantsAndTransactionCostsMember2022-03-310001757097cntg:CapitalReserveAfterIssuanceOfSharesAndTransactionCostsMember2022-01-310001757097ifrs-full:LeaseLiabilitiesMemberifrs-full:TopOfRangeMember2022-03-310001757097ifrs-full:LeaseLiabilitiesMemberifrs-full:BottomOfRangeMember2022-03-310001757097ifrs-full:LeaseLiabilitiesMemberifrs-full:TopOfRangeMember2021-12-310001757097ifrs-full:LeaseLiabilitiesMemberifrs-full:BottomOfRangeMember2021-12-310001757097cntg:LoanFacilityMembercntg:FloorRateMember2022-01-310001757097ifrs-full:DiscontinuedOperationsMember2022-01-012022-03-310001757097ifrs-full:DiscontinuedOperationsMember2021-01-012021-03-310001757097srt:ScenarioPreviouslyReportedMember2021-01-012021-12-310001757097srt:RevisionOfPriorPeriodReclassificationAdjustmentMember2021-01-012021-12-310001757097cntg:IfrsRestrictedStockUnitsRsusMembercntg:ManagementBoardAndEmployeesMembercntg:LongTermIncentivePlanMember2022-01-012022-03-310001757097cntg:StockOptionsMembercntg:EquityShareOption2017EquitySettledMember2022-01-012022-03-310001757097cntg:OtherRsusToCeoMembercntg:ShareBasedAwardsAnnualRestrictedStockUnitsMembercntg:IfrsChiefExecutiveOfficerMember2022-02-012022-02-010001757097cntg:IfrsRestrictedStockUnitsRsusMembercntg:Mr.JustMember2022-01-012022-03-310001757097cntg:IfrsRestrictedStockUnitsRsusMembercntg:IfrsFormerChiefExecutiveOfficerMember2022-01-012022-03-310001757097cntg:LongTermIncentivesMembercntg:SupervisoryBoardMembercntg:LeadershipTransitionMember2022-06-222022-06-220001757097cntg:LongTermIncentivesMembercntg:ViceChairmanMembercntg:LeadershipTransitionMember2022-06-222022-06-220001757097cntg:LongTermIncentivesMembercntg:ChairmanOfCompensationCommitteeMembercntg:LeadershipTransitionMember2022-06-222022-06-220001757097cntg:LongTermIncentivesMembercntg:ChairmanOfAuditCommitteeMembercntg:LeadershipTransitionMember2022-06-222022-06-220001757097cntg:LongTermIncentivesMembercntg:ChairmanMembercntg:LeadershipTransitionMember2022-06-222022-06-220001757097cntg:RostockHeadquartersBuildingMemberifrs-full:NotLaterThanOneYearMember2022-03-310001757097cntg:RostockHeadquartersBuildingMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2022-03-310001757097cntg:RostockHeadquartersBuildingMemberifrs-full:LaterThanFiveYearsMember2022-03-310001757097cntg:OfficeEquipmentAndStorageSpacesMemberifrs-full:NotLaterThanOneYearMember2022-03-310001757097cntg:OfficeEquipmentAndStorageSpacesMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2022-03-310001757097cntg:RostockHeadquartersBuildingMemberifrs-full:NotLaterThanOneYearMember2021-12-310001757097cntg:RostockHeadquartersBuildingMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2021-12-310001757097cntg:RostockHeadquartersBuildingMemberifrs-full:LaterThanFiveYearsMember2021-12-310001757097cntg:OfficeEquipmentAndStorageSpacesMemberifrs-full:NotLaterThanOneYearMember2021-12-310001757097cntg:OfficeEquipmentAndStorageSpacesMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2021-12-310001757097cntg:TradeReceivablesAndContractAssetsMemberifrs-full:NotLaterThanOneMonthMember2022-03-310001757097cntg:TradeReceivablesAndContractAssetsMemberifrs-full:LaterThanThreeMonthsMember2022-03-310001757097cntg:TradeReceivablesAndContractAssetsMemberifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember2022-03-310001757097cntg:TradeReceivablesAndContractAssetsMemberifrs-full:CurrentMember2022-03-310001757097ifrs-full:DiscontinuedOperationsMember2022-03-310001757097cntg:TradeReceivablesAndContractAssetsMember2022-03-310001757097cntg:TradeReceivablesAndContractAssetsMemberifrs-full:NotLaterThanOneMonthMember2021-12-310001757097cntg:TradeReceivablesAndContractAssetsMemberifrs-full:LaterThanThreeMonthsMember2021-12-310001757097cntg:TradeReceivablesAndContractAssetsMemberifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember2021-12-310001757097cntg:TradeReceivablesAndContractAssetsMemberifrs-full:CurrentMember2021-12-310001757097ifrs-full:DiscontinuedOperationsMember2021-12-310001757097cntg:TradeReceivablesAndContractAssetsMember2021-12-310001757097cntg:OverdraftFacilityTwoMembercntg:BankOverdraftsOneAndThreeMember2022-03-310001757097cntg:OverdraftFacilityMembercntg:BankOverdraftsTwoMember2022-03-310001757097cntg:OverdraftFacilityMembercntg:BankOverdraftsTwoMember2021-12-310001757097cntg:IfrsRestrictedStockUnitsRsusMembercntg:ShareBasedAwardsAnnualRestrictedStockUnitsMembercntg:IfrsChiefExecutiveOfficerMember2022-02-012022-02-010001757097srt:ScenarioPreviouslyReportedMember2021-12-310001757097srt:RevisionOfPriorPeriodReclassificationAdjustmentMember2021-12-310001757097ifrs-full:OtherAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMember2022-03-310001757097ifrs-full:TopOfRangeMember2022-01-012022-03-310001757097ifrs-full:BottomOfRangeMember2022-01-012022-03-310001757097cntg:IfrsRestrictedStockUnitsRsusMembercntg:ManagementBoardAndEmployeesMembercntg:LongTermIncentivePlanMembercntg:VestingInFourTranchesMember2021-01-012021-03-310001757097cntg:IfrsShareBasedPaymentArrangementOptionMembercntg:LeadershipTransitionMembercntg:ChiefInformationOfficerMember2022-06-290001757097cntg:StockOptionsMembercntg:LongTermIncentivePlanMember2022-03-310001757097cntg:StockOptionsMembercntg:EquityShareOption2017EquitySettledMember2022-03-310001757097cntg:IfrsRestrictedStockUnitsRsusMembercntg:LongTermIncentivePlanMember2022-03-310001757097cntg:IfrsRestrictedStockUnitsRsusMembercntg:LongTermIncentivePlanMember2022-01-012022-03-310001757097cntg:IfrsRestrictedStockUnitsRsusMembercntg:IfrsFormerChiefExecutiveOfficerMember2022-04-302022-04-300001757097cntg:TimeBasedRestrictedStockUnitsMembercntg:IfrsChiefFinancialOfficerMembercntg:LeadershipTransitionMember2022-06-220001757097cntg:PerformanceBasedRestrictedStockUnitsMembercntg:IfrsChiefFinancialOfficerMembercntg:LeadershipTransitionMember2022-06-220001757097cntg:LongTermIncentivesMembercntg:LeadershipTransitionMember2022-06-220001757097cntg:IfrsRestrictedStockUnitsRsusMembercntg:ShareBasedAwardsAnnualRestrictedStockUnitsMembercntg:IfrsChiefExecutiveOfficerMember2022-02-010001757097cntg:IfrsRestrictedStockUnitsRsusMembercntg:IfrsChiefExecutiveOfficerMember2022-02-010001757097cntg:PharmaceuticalPartnerMembercntg:PharmaceuticalSegmentMember2022-01-012022-03-310001757097ifrs-full:InterestRateMeasurementInputMember2022-03-310001757097ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember2022-03-310001757097cntg:TimeToMaturityMeasurementInputMember2022-03-310001757097cntg:SharePriceMeasurementInputMember2022-03-310001757097cntg:ExercisePriceMeasurementInputMember2022-03-310001757097cntg:DividendYieldMeasurementInputMember2022-03-310001757097ifrs-full:InterestRateMeasurementInputMember2022-01-310001757097ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember2022-01-310001757097cntg:TimeToMaturityMeasurementInputMember2022-01-310001757097cntg:SharePriceMeasurementInputMember2022-01-310001757097cntg:ExercisePriceMeasurementInputMember2022-01-310001757097cntg:DividendYieldMeasurementInputMember2022-01-310001757097ifrs-full:CapitalReserveMember2022-01-012022-01-3100017570972022-01-012022-01-310001757097cntg:IfrsShareBasedPaymentArrangementOptionMembercntg:LeadershipTransitionMembercntg:ChiefInformationOfficerMember2022-06-292022-06-290001757097cntg:LongTermIncentivesMembercntg:LeadershipTransitionMember2022-06-222022-06-220001757097cntg:IfrsRestrictedStockUnitsRsusMembercntg:ManagementBoardAndEmployeesMembercntg:LongTermIncentivePlanMembercntg:VestingInFourTranchesMember2022-02-012022-02-010001757097cntg:IfrsRestrictedStockUnitsRsusMembercntg:IfrsChiefExecutiveOfficerMember2022-02-012022-02-010001757097cntg:RsuGrantedFourMembercntg:LongTermIncentivePlanMember2022-01-012022-03-310001757097cntg:PerformanceBasedRestrictedStockUnitsMembercntg:IfrsShareBasedPaymentArrangementTrancheTwoMembercntg:IfrsChiefExecutiveOfficerMember2022-02-012022-02-010001757097cntg:PerformanceBasedRestrictedStockUnitsMembercntg:IfrsShareBasedPaymentArrangementTrancheOneMembercntg:IfrsChiefExecutiveOfficerMember2022-02-012022-02-010001757097cntg:ShareBasedAwardsSubjectToTimeVestingMembercntg:IfrsChiefExecutiveOfficerMember2022-01-012022-03-310001757097cntg:RsuGrantedTwoMembercntg:LongTermIncentivePlanMember2022-01-012022-03-310001757097cntg:RsuGrantedOneMembercntg:LongTermIncentivePlanMember2022-01-012022-03-310001757097cntg:RsuGrantedFiveMembercntg:LongTermIncentivePlanMember2022-01-012022-03-310001757097cntg:OverdraftFacilityTwoMember2022-03-310001757097cntg:OverdraftFacilityThreeMember2022-03-310001757097cntg:OverdraftFacilityOneMember2022-03-310001757097cntg:LoanFacilityMember2022-01-310001757097ifrs-full:CapitalReserveMember2022-01-310001757097cntg:SecuredBankLoansWithMaturityPeriod2022To27Member2022-03-310001757097cntg:SecuredBankLoansWithMaturityPeriod2017To22Member2022-03-310001757097cntg:BankOverdraftsTwoMember2022-03-310001757097cntg:BankOverdraftsThreeMember2022-03-310001757097cntg:BankOverdraftsOneMember2022-03-310001757097cntg:SecuredBankLoansWithMaturityPeriod2017To22Member2021-12-310001757097cntg:BankOverdraftsTwoMember2021-12-310001757097cntg:BankOverdraftsThreeMember2021-12-310001757097cntg:BankOverdraftsOneMember2021-12-3100017570972022-01-310001757097cntg:IfrsRestrictedStockUnitsRsusMember2022-01-012022-03-310001757097cntg:PerformanceBasedRestrictedStockUnitsMembercntg:IfrsShareBasedPaymentArrangementTrancheTwoMembersrt:ChiefExecutiveOfficerMember2022-01-012022-03-310001757097cntg:PerformanceBasedRestrictedStockUnitsMembercntg:IfrsShareBasedPaymentArrangementTrancheOneMembersrt:ChiefExecutiveOfficerMember2022-01-012022-03-3100017570972021-01-012021-12-310001757097ifrs-full:InterestRateRiskMember2022-01-012022-03-310001757097ifrs-full:InterestRateRiskMember2021-01-012021-12-310001757097cntg:UniversitairMedischCentrumUtrechtMember2020-12-310001757097cntg:UniversitairMedischCentrumUtrechtMember2018-11-080001757097ifrs-full:OtherAssetsMember2021-12-310001757097ifrs-full:LeaseLiabilitiesMember2022-03-310001757097ifrs-full:BorrowingsByNameMember2022-03-310001757097cntg:SecuredCreditLinesMember2022-03-310001757097cntg:IfrsBankOverdraftsMember2022-03-3100017570972022-03-310001757097ifrs-full:LeaseLiabilitiesMember2021-12-310001757097ifrs-full:BorrowingsByNameMember2021-12-310001757097cntg:SecuredCreditLinesMember2021-12-310001757097cntg:IfrsBankOverdraftsMember2021-12-3100017570972021-12-310001757097ifrs-full:OtherAssetsMember2022-03-310001757097cntg:LoanFacilityTrancheTwoMember2022-01-012022-01-310001757097cntg:LoanFacilityTrancheOneMember2022-01-012022-01-310001757097cntg:LoanFacilityTrancheTwoMember2022-01-310001757097ifrs-full:OtherAssetsMembercntg:RostockHeadquartersBuildingMember2022-03-310001757097ifrs-full:OtherAssetsMembercntg:BerlinOfficesMember2022-03-310001757097cntg:MaximumAdditionalRestrictedStockUnitMembercntg:IfrsChiefExecutiveOfficerMemberifrs-full:TopOfRangeMembercntg:VolumeWeightedAverageStockPricePriorToChangeBetweenUsd5AndUsd15Member2022-02-012022-02-010001757097cntg:MaximumAdditionalRestrictedStockUnitMembercntg:IfrsChiefExecutiveOfficerMemberifrs-full:BottomOfRangeMembercntg:VolumeWeightedAverageStockPricePriorToChangeMoreThanUsd15Member2022-02-012022-02-010001757097cntg:MaximumAdditionalRestrictedStockUnitMembercntg:IfrsChiefExecutiveOfficerMemberifrs-full:BottomOfRangeMembercntg:VolumeWeightedAverageStockPricePriorToChangeBetweenUsd5AndUsd15Member2022-02-012022-02-010001757097ifrs-full:OrdinarySharesMember2022-01-012022-03-310001757097ifrs-full:OrdinarySharesMember2021-01-012021-12-310001757097ifrs-full:OperatingSegmentsMember2022-01-012022-03-310001757097ifrs-full:OperatingSegmentsMember2021-01-012021-03-310001757097ifrs-full:OperatingSegmentsMembercntg:PharmaceuticalSegmentMember2022-01-012022-03-310001757097ifrs-full:OperatingSegmentsMembercntg:DiagnosticsSegmentMember2022-01-012022-03-310001757097cntg:IfrsCorporateMember2022-01-012022-03-310001757097ifrs-full:OperatingSegmentsMembercntg:PharmaceuticalSegmentMember2021-01-012021-03-310001757097ifrs-full:OperatingSegmentsMembercntg:DiagnosticsSegmentMember2021-01-012021-03-310001757097cntg:IfrsCorporateMember2021-01-012021-03-3100017570972021-01-012021-03-31cntg:trancheiso4217:CHFcntg:itemcntg:EquityInstrumentscntg:Optionsiso4217:EURiso4217:USDxbrli:sharesiso4217:USDxbrli:pureiso4217:EURxbrli:sharesxbrli:sharescntg:Ycntg:customercntg:installment
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the date of July 15, 2022
Commission File Number 001-39124
Centogene N.V.
(Translation of registrant’s name into English)
Am Strande 7
18055 Rostock
Germany
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F..⌧.. Form 40-F.◻
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ◻
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ◻
Centogene N.V.
On July 15, 2022, Centogene N.V. (the “Company”) issued a press release reporting its financial results for the three months ended March 31, 2022. A copy of the press release is attached hereto as Exhibit 99.1.
Attached hereto as Exhibit 99.2 and 99.3 are also the financial statements of the Company for the three months ended March 31, 2022 and the Management’s Discussion and Analysis of Financial Condition and Results of Operations for the three months ended March 31, 2022, respectively. All exhibits attached hereto are incorporated by reference herein.
Exhibit 99.1 to this Report on Form 6-K shall not be deemed “filed” for purposes of Section 18 of the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the U.S. Securities Act of 1933, as amended, or the Exchange Act.
Exhibits 99.2 and 99.3 to this Report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number 333-234551) of the Company and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | | |
| CENTOGENE N.V. |
| |
| |
Date: July 15, 2022 | |
| |
| |
| By: | /s/ Jose Miguel Coego Rios |
| | Name: | Jose Miguel Coego Rios |
| | Title: | Chief Financial Officer |
Centogene NV (NASDAQ:CNTG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Centogene NV (NASDAQ:CNTG)
Historical Stock Chart
From Apr 2023 to Apr 2024
